Antiangiogenesis May Not Be a Universal Booster of EGFR Tyrosine Kinase Inhibitors.

Wu, Tsung-Che; Lin, Chia-Chi

Wu, Tsung-Che; Lin, Chia-Chi.

Afiliação

Wu TC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Department of Oncology, National Taiwan University Biomedical Park Hospital, Hsinchu, Taiwan.
Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: cclin1@ntu.edu.tw.

J Thorac Oncol ; 17(9): 1063-1066, 2022 09.

Article em En | MEDLINE | ID: mdl-36031284

Assuntos

Neoplasias Pulmonares; Receptores ErbB; Humanos; Inibidores de Proteínas Quinases

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google